Skip to main content
Top
Published in: Inflammation 2/2016

01-04-2016 | ORIGINAL ARTICLE

Morphine Suppresses T helper Lymphocyte Differentiation to Th1 Type Through PI3K/AKT Pathway

Authors: Mao Mao, Yanning Qian, Jie Sun

Published in: Inflammation | Issue 2/2016

Login to get access

Abstract

To investigate the effect of morphine on T helper lymphocyte differentiation and PI3K/AKT pathway mechanism, CD4+ lymphocytes were treated by phorbol-myristate-acetate (25 ng/ml) (PMA) plus ionomycin (1 μg/ml) in the presence of various concentrations of morphine (25, 50, 100, 200 ng/ml) for 4 h. Th1 and Th2 subsets, supernatant cytokines, and PI3K, AKT, and protein kinase C-theta (PKC-θ) levels were detected. The Th1 cell percentage, Th1-derived cytokines, and ratio of Th1/Th2 decreased in the presence of morphine in a concentration-dependent manner. However, Th2 cell percentage kept stable after morphine treatment. The phosphorylation of PI3K and AKT decreased, but the phosphorylation of PKC-θ did not change in the presence of morphine. The decreased percentage of Th1 cells and ratio of Th1/Th2 was recovered by naloxone concentration-dependently. Morphine can inhibit the differentiation of Th1 lymphocytes and decrease the ratio of Th1/Th2 via the pathway of PI3K/AKT. The effect can be inhibited by naloxone.
Literature
1.
go back to reference Knutson, K.L., and M.L. Disis. 2005. Tumor antigen-specific T helper cells in cancer immunity and immunotherapy. Cancer Immunology, Immunotherapy 54: 721–8.CrossRefPubMed Knutson, K.L., and M.L. Disis. 2005. Tumor antigen-specific T helper cells in cancer immunity and immunotherapy. Cancer Immunology, Immunotherapy 54: 721–8.CrossRefPubMed
2.
go back to reference De Monte, L., M. Reni, E. Tassi, et al. 2011. Intratumor T helper type 2 cell infiltrate correlates with cancer-associated fibroblast thymic stromal lymphopoietin production and reduced survival in pancreatic cancer. The Journal of Experimental Medicine 208: 469–78.CrossRefPubMedPubMedCentral De Monte, L., M. Reni, E. Tassi, et al. 2011. Intratumor T helper type 2 cell infiltrate correlates with cancer-associated fibroblast thymic stromal lymphopoietin production and reduced survival in pancreatic cancer. The Journal of Experimental Medicine 208: 469–78.CrossRefPubMedPubMedCentral
3.
go back to reference Tosolini, M., A. Kirilovsky, B. Mlecnik, et al. 2011. Clinical impact of different classes of infiltrating T cytotoxic and helper cells (Th1, th2, treg, th17) in patients with colorectal cancer. Cancer Research 71: 1263–71.CrossRefPubMed Tosolini, M., A. Kirilovsky, B. Mlecnik, et al. 2011. Clinical impact of different classes of infiltrating T cytotoxic and helper cells (Th1, th2, treg, th17) in patients with colorectal cancer. Cancer Research 71: 1263–71.CrossRefPubMed
4.
go back to reference Ubukata, H., G. Motohashi, T. Tabuchi, et al. 2010. Evaluations of interferon-γ/interleukin-4 ratio and neutrophil/lymphocyte ratio as prognostic indicators in gastric cancer patients. Journal of Surgical Oncology 102: 742–7.CrossRefPubMed Ubukata, H., G. Motohashi, T. Tabuchi, et al. 2010. Evaluations of interferon-γ/interleukin-4 ratio and neutrophil/lymphocyte ratio as prognostic indicators in gastric cancer patients. Journal of Surgical Oncology 102: 742–7.CrossRefPubMed
5.
go back to reference Pollizzi, K.N., and J.D. Powell. 2014. Integrating canonical and metabolic signalling programmes in the regulation of T cell responses. Nature Reviews Immunology 14: 435–46.CrossRefPubMedPubMedCentral Pollizzi, K.N., and J.D. Powell. 2014. Integrating canonical and metabolic signalling programmes in the regulation of T cell responses. Nature Reviews Immunology 14: 435–46.CrossRefPubMedPubMedCentral
6.
go back to reference Ding, R., J. Tang, H. Gao, et al. 2012. New methymycin derivatives of Streptomyces venezuelae ATCC 15439 and their inhibitory effects on human T cell proliferation mediated by PMA/ionomycin. Archives of Pharmacal Research 35: 1567–72.CrossRefPubMed Ding, R., J. Tang, H. Gao, et al. 2012. New methymycin derivatives of Streptomyces venezuelae ATCC 15439 and their inhibitory effects on human T cell proliferation mediated by PMA/ionomycin. Archives of Pharmacal Research 35: 1567–72.CrossRefPubMed
7.
go back to reference Gao, M., J. Sun, W. Jin, et al. 2012. Morphine, but not ketamine, decreases the ratio of Th1/Th2 in CD4-positive cells through T-bet and GATA3. Inflammation 35: 1069–77.CrossRefPubMed Gao, M., J. Sun, W. Jin, et al. 2012. Morphine, but not ketamine, decreases the ratio of Th1/Th2 in CD4-positive cells through T-bet and GATA3. Inflammation 35: 1069–77.CrossRefPubMed
8.
go back to reference Kraus, J. 2012. Expression and functions of μ-opioid receptors and cannabinoid receptors type 1 in T lymphocytes. Annals of the New York Academy of Sciences 1261: 1–6.CrossRefPubMed Kraus, J. 2012. Expression and functions of μ-opioid receptors and cannabinoid receptors type 1 in T lymphocytes. Annals of the New York Academy of Sciences 1261: 1–6.CrossRefPubMed
9.
go back to reference Madishetti, S., N. Schneble, C. König, et al. 2014. PI3Kγ integrates cAMP and Akt signalling of the μ-opioid receptor. British Journal of Pharmacology 171: 3328–37.CrossRefPubMedPubMedCentral Madishetti, S., N. Schneble, C. König, et al. 2014. PI3Kγ integrates cAMP and Akt signalling of the μ-opioid receptor. British Journal of Pharmacology 171: 3328–37.CrossRefPubMedPubMedCentral
10.
go back to reference Higuchi, S., M. Ii, P. Zhu, et al. 2012. Delta-opioid receptor activation promotes mesenchymal stem cell survival via PKC/STAT3 signaling pathway. Circulation Journal 76: 204–12.CrossRefPubMed Higuchi, S., M. Ii, P. Zhu, et al. 2012. Delta-opioid receptor activation promotes mesenchymal stem cell survival via PKC/STAT3 signaling pathway. Circulation Journal 76: 204–12.CrossRefPubMed
11.
go back to reference Cook, K.D., and J. Miller. 2010. TCR-dependent translational control of GATA-3 enhances Th2 differentiation. Journal of Immunology 185: 3209–16.CrossRef Cook, K.D., and J. Miller. 2010. TCR-dependent translational control of GATA-3 enhances Th2 differentiation. Journal of Immunology 185: 3209–16.CrossRef
12.
go back to reference Chen, H., T. Fu, W.K. Suh, et al. 2014. CD4 T cells require ICOS-mediated PI3K signaling to increase T-Bet expression in the setting of anti-CTLA-4 therapy. Cancer Immunologic Research 2: 167–76.CrossRef Chen, H., T. Fu, W.K. Suh, et al. 2014. CD4 T cells require ICOS-mediated PI3K signaling to increase T-Bet expression in the setting of anti-CTLA-4 therapy. Cancer Immunologic Research 2: 167–76.CrossRef
13.
go back to reference Gao, M., W. Jin, Y. Qian, et al. 2011. Effect of N-methyl-D-aspartate receptor antagonist on T helper cell differentiation induced by phorbol-myristate-acetate and ionomycin. Cytokine 56: 458–65.CrossRefPubMed Gao, M., W. Jin, Y. Qian, et al. 2011. Effect of N-methyl-D-aspartate receptor antagonist on T helper cell differentiation induced by phorbol-myristate-acetate and ionomycin. Cytokine 56: 458–65.CrossRefPubMed
14.
go back to reference Lee, K., P. Gudapati, S. Dragovic, et al. 2010. Mammalian target of rapamycin protein complex 2 regulates differentiation of Th1 and Th2 cell subsets via distinct signaling pathways. Immunity 32: 743–53.CrossRefPubMedPubMedCentral Lee, K., P. Gudapati, S. Dragovic, et al. 2010. Mammalian target of rapamycin protein complex 2 regulates differentiation of Th1 and Th2 cell subsets via distinct signaling pathways. Immunity 32: 743–53.CrossRefPubMedPubMedCentral
15.
go back to reference Marsland, B.J., T.J. Soos, G. Späth, et al. 2004. Protein kinase C theta is critical for the development of in vivo T helper (Th)2 cell but not Th1 cell responses. The Journal of Experimental Medicine 200: 181–9.CrossRefPubMedPubMedCentral Marsland, B.J., T.J. Soos, G. Späth, et al. 2004. Protein kinase C theta is critical for the development of in vivo T helper (Th)2 cell but not Th1 cell responses. The Journal of Experimental Medicine 200: 181–9.CrossRefPubMedPubMedCentral
16.
go back to reference Zhang, L., J.S. Belkowski, T. Briscoe, et al. 2012. Regulation of mu opioid receptor expression in developing T cells. Journal of Neuroimmune Pharmacology 7: 835–42.CrossRefPubMedPubMedCentral Zhang, L., J.S. Belkowski, T. Briscoe, et al. 2012. Regulation of mu opioid receptor expression in developing T cells. Journal of Neuroimmune Pharmacology 7: 835–42.CrossRefPubMedPubMedCentral
17.
go back to reference Roy, S., F. Ethuin, C. Bourgeois, et al. 2004. Chronic morphine treatment differentiates T helper cells to Th2 effector cells by modulating transcription factors GATA 3 and T-bet. Journal of Neuroimmunology 147: 78–81.CrossRefPubMed Roy, S., F. Ethuin, C. Bourgeois, et al. 2004. Chronic morphine treatment differentiates T helper cells to Th2 effector cells by modulating transcription factors GATA 3 and T-bet. Journal of Neuroimmunology 147: 78–81.CrossRefPubMed
18.
go back to reference Hammoud, H.A., G. Aymard, P. Lechat, et al. 2011. Relationships between plasma concentrations of morphine, morphine-3-glucuronide, morphine-6-glucuronide, and intravenous morphine titration outcomes in the postoperative period. Fundamental and Clinical Pharmacology 25: 518–27.CrossRefPubMed Hammoud, H.A., G. Aymard, P. Lechat, et al. 2011. Relationships between plasma concentrations of morphine, morphine-3-glucuronide, morphine-6-glucuronide, and intravenous morphine titration outcomes in the postoperative period. Fundamental and Clinical Pharmacology 25: 518–27.CrossRefPubMed
19.
go back to reference Greeneltch, K.M., A.E. Kelly-Welch, Y. Shi, et al. 2005. Chronic morphine treatment promotes specific Th2 cytokine production by Murine T cells in vitro via a Fas/Fas ligand-dependent mechanism. The Journal of Immunology 175: 4999–5005.CrossRefPubMed Greeneltch, K.M., A.E. Kelly-Welch, Y. Shi, et al. 2005. Chronic morphine treatment promotes specific Th2 cytokine production by Murine T cells in vitro via a Fas/Fas ligand-dependent mechanism. The Journal of Immunology 175: 4999–5005.CrossRefPubMed
20.
go back to reference Roy, S., J. Wang, R. Charboneau, et al. 2005. Morphine induces CD4+ T cell IL-4 expression through an adenylyl cyclase mechanism independent of the protein kinase a pathway. Journal of Immunology 175: 6361–6367.CrossRef Roy, S., J. Wang, R. Charboneau, et al. 2005. Morphine induces CD4+ T cell IL-4 expression through an adenylyl cyclase mechanism independent of the protein kinase a pathway. Journal of Immunology 175: 6361–6367.CrossRef
Metadata
Title
Morphine Suppresses T helper Lymphocyte Differentiation to Th1 Type Through PI3K/AKT Pathway
Authors
Mao Mao
Yanning Qian
Jie Sun
Publication date
01-04-2016
Publisher
Springer US
Published in
Inflammation / Issue 2/2016
Print ISSN: 0360-3997
Electronic ISSN: 1573-2576
DOI
https://doi.org/10.1007/s10753-016-0310-x

Other articles of this Issue 2/2016

Inflammation 2/2016 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.